These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 18317433)

  • 1. PPARgamma: a novel molecular target in lung disease.
    Hart CM; Roman J; Reddy R; Sime PJ
    J Investig Med; 2008 Feb; 56(2):515-7. PubMed ID: 18317433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peroxisome proliferator-activated receptor gamma and lung cancer biology: implications for therapy.
    Roman J
    J Investig Med; 2008 Feb; 56(2):528-33. PubMed ID: 18317436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peroxisome proliferator-activated receptor gamma as modulator of inflammation in pulmonary sarcoidosis.
    Pejcić T; Stanković I; Petković TR; Borovac DN; Djordjević I; Jeftović-Stoimenov T
    Srp Arh Celok Lek; 2013; 141(9-10):705-9. PubMed ID: 24364239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The antifibrogenic potential of PPARgamma ligands in pulmonary fibrosis.
    Sime PJ
    J Investig Med; 2008 Feb; 56(2):534-8. PubMed ID: 18317437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of inflammation by PPARs: a future approach to treat lung inflammatory diseases?
    Becker J; Delayre-Orthez C; Frossard N; Pons F
    Fundam Clin Pharmacol; 2006 Oct; 20(5):429-47. PubMed ID: 16968414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peroxisome proliferator-activated receptor γ: innate protection from excessive fibrogenesis and potential therapeutic target in systemic sclerosis.
    Wei J; Bhattacharyya S; Varga J
    Curr Opin Rheumatol; 2010 Nov; 22(6):671-6. PubMed ID: 20693905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peroxisome proliferator-activated receptor gamma and cardiovascular diseases.
    Takano H; Komuro I
    Circ J; 2009 Feb; 73(2):214-20. PubMed ID: 19129679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. From the History of the Croatian Dermatovenereological Society - The Croatian Medical Association and an Overview of Important Information Regarding the Journal Acta Dermatovenerologica Croatica.
    Dobrić I
    Acta Dermatovenerol Croat; 2018 Dec; 26(4):344-348. PubMed ID: 30665489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Peroxisome Proliferator-Activated Receptor (PPAR)-
    Schubert M; Becher S; Wallert M; Maeß MB; Abhari M; Rennert K; Mosig AS; Große S; Heller R; Grün M; Lorkowski S
    Mol Pharmacol; 2020 Mar; 97(3):212-225. PubMed ID: 31871304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PPAR Gamma: From Definition to Molecular Targets and Therapy of Lung Diseases.
    Carvalho MV; Gonçalves-de-Albuquerque CF; Silva AR
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33467433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Up-regulation of p21 gene expression by peroxisome proliferator-activated receptor gamma in human lung carcinoma cells.
    Han S; Sidell N; Fisher PB; Roman J
    Clin Cancer Res; 2004 Mar; 10(6):1911-9. PubMed ID: 15041706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of PPARγ-mediated signalling in skin biology and pathology: new targets and opportunities for clinical dermatology.
    Ramot Y; Mastrofrancesco A; Camera E; Desreumaux P; Paus R; Picardo M
    Exp Dermatol; 2015 Apr; 24(4):245-51. PubMed ID: 25644500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peroxisome proliferator-activated receptor gamma in bladder cancer: a promising therapeutic target.
    Mansure JJ; Nassim R; Kassouf W
    Cancer Biol Ther; 2009 Apr; 8(7):6-15. PubMed ID: 19417560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peroxisome proliferator-activated receptors as novel targets in lung disease.
    Belvisi MG; Hele DJ
    Chest; 2008 Jul; 134(1):152-7. PubMed ID: 18628217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel approach to treat insulin resistance, type 2 diabetes, and the metabolic syndrome: simultaneous activation of PPARalpha, PPARgamma, and PPARdelta.
    Evans JL; Lin JJ; Goldfine ID
    Curr Diabetes Rev; 2005 Aug; 1(3):299-307. PubMed ID: 18220606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peroxisome proliferator-activated receptor gamma as a novel therapeutic target in asthma.
    Park SJ; Lee YC
    J Asthma; 2008; 45(1):1-8. PubMed ID: 18259989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peroxisome proliferator-activated receptors (PPARs) and the human skin: importance of PPARs in skin physiology and dermatologic diseases.
    Sertznig P; Seifert M; Tilgen W; Reichrath J
    Am J Clin Dermatol; 2008; 9(1):15-31. PubMed ID: 18092840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Roles of peroxisome proliferator-activated receptor-alpha and -gamma in the development of non-small cell lung cancer.
    Li MY; Yuan H; Ma LT; Kong AW; Hsin MK; Yip JH; Underwood MJ; Chen GG
    Am J Respir Cell Mol Biol; 2010 Dec; 43(6):674-83. PubMed ID: 20081051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peroxisome Proliferator-activated Receptor-γ Deficiency Exacerbates Fibrotic Response to Mycobacteria Peptide in Murine Sarcoidosis Model.
    Malur A; Mohan A; Barrington RA; Leffler N; Malur A; Muller-Borer B; Murray G; Kew K; Zhou C; Russell J; Jones JL; Wingard CJ; Barna BP; Thomassen MJ
    Am J Respir Cell Mol Biol; 2019 Aug; 61(2):198-208. PubMed ID: 30741559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PPARgamma and its ligands: therapeutic implications in cardiovascular disease.
    Villacorta L; Schopfer FJ; Zhang J; Freeman BA; Chen YE
    Clin Sci (Lond); 2009 Feb; 116(3):205-18. PubMed ID: 19118492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.